China Animal Husbandry Ind. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Animal Husbandry Ind. with three other
companies in this sector in CHINA :
China Biologic Products Holdings Inc
sales of 3.48 billion Chinese Renmimbi [US$489.46 million]
of which 84%
was Biopharmaceutical Products),
Beijing Tiantan Biologic.
(3.28 billion Chinese Renmimbi [US$462.18 million]
of which 100%
was Blood products), and
Hualan Biological Engineering Inc
(3.70 billion Chinese Renmimbi [US$521.06 million]
of which 71%
was Blood Product).
During the year ended December of 2019, sales at
China Animal Husbandry Ind. were 4.12 billion Chinese Renmimbi (US$579.90 million).
decrease of 7.1%
versus 2018, when the company's sales were 4.43 billion Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, China Animal Husbandry Ind. had sales
of 4.03 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 10.2% decline
in Animal Disease Treatment, from 903.68 million Chinese Renmimbi to 811.09 million Chinese Renmimbi.
There were also decreases in sales in
Animal Feedstuff (down 4.7% to 2.14 billion Chinese Renmimbi)
Animal Disease and Epidemic Prevention (down 9.3% to 1.14 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Other (up 0.7% to 29.49 million Chinese Renmimbi)